Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
When it comes to colorectal liver metastases, how you operate matters less than you might think. A large meta-analysis of four randomized trials found that laparoscopic and open liver resection yield identical long-term survival outcomes. The minimally invasive approach does win on recovery, with lower complication rates and shorter hospital stays.
For patients with colorectal cancer that has spread to the liver, surgeons now have clearer guidance on choosing their approach. A major individual participant data meta-analysis pooling four randomized controlled trials found that laparoscopic liver resection (LLR) and open liver resection (OLR) produce virtually identical long-term survival outcomes — but the minimally invasive route comes with meaningful short-term advantages.
The analysis included 761 patients across trials conducted in Norway, Spain, and multiple European centers, with a median follow-up of 93 months. Both groups showed a five-year overall survival rate of 53% and a disease-free survival rate of 46%, confirming that neither surgical method holds an oncologic edge.
By the Numbers:
Why it matters: With equivalent cancer outcomes, the lower complication rates and faster recovery associated with laparoscopic surgery give clinicians a strong case for preferring the minimally invasive approach when technically feasible — improving patient experience without compromising oncologic results.
